Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
$57.8M Sell
468,525
-22,236
-5% -$2.7M 0.73% 23
2013
Q4
$56M Sell
490,761
-64,158
-12% -$7.3M 0.68% 25
2013
Q3
$62.1M Sell
554,919
-27,509
-5% -$2.98M 0.81% 16
2013
Q2
$57.4M Buy
+582,428
New +$60.4M 0.79% 18

Other funds holding AMGN

F&C Asset Management's AMGN Position: Q1 2014 in Review

F&C Asset Management reduced its Amgen (AMGN) stake by 4.5% in Q1 2014, selling an estimated $2.7M and leaving 468,525 shares worth $57.8M. The position accounts for 0.73% of the portfolio, ranked #23.

F&C Asset Management first reported a position in AMGN in Q2 2013 and has held it in 4 quarters since. The position peaked at $62.1M in Q3 2013. 1,180 funds tracked by Wall St. Rank hold AMGN as of Q1 2014.

  • F&C Asset Management held 468,525 shares of Amgen worth $57.8M as of Q1 2014.
  • F&C Asset Management sold 22,236 Amgen shares in Q1 2014, an estimated $2.7M.
  • Amgen made up 0.73% of F&C Asset Management's portfolio in Q1 2014, its #23 holding.
  • F&C Asset Management first reported a position in Amgen in Q2 2013 and has held it in 4 quarters since.
  • F&C Asset Management's Amgen position peaked at $62.1M in Q3 2013.
  • 1,180 funds tracked by Wall St. Rank held Amgen as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.